Lobbying Filing Details

Total Spending

$90,000

Activities

2

Lobbyists

1

Gov't Entities

5

Filing Information
Filing UUID:
73e4f47e-cb1c-402d-9102-93ee000fdb3f
Type:
Q4 - 4th Quarter - Report
Period:
2025 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 20, 2026 at 9:47 PM
Income:
$0
Expenses:
$90,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Amanda Pezalla
Registrant
DAIICHI SANKYO, INC.
Basking Ridge, New Jersey
Client
DAIICHI SANKYO INC
District of Columbia, United States of America
Lobbying Activities (2)
Activity 1
Health Issues

Discussions regarding H.R.946, the ORPHAN Cures Act Discussions related to H.R.2319, the Women and Lung Cancer Research and Preventative Services Act Discussions related to the Protecting Patient Access to Cancer and Complex Therapies Act reintroduction

Foreign Entity Issues: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

Lobbyists (1)
  • AMANDA PEZALLA
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Taxation/Internal Revenue Code

Discussions regarding tax reform and tariffs

Foreign Entity Issues: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

Lobbyists (1)
  • AMANDA PEZALLA
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Treasury, Dept of

Source: LDA.gov, data retrieved November 11, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.